Cargando…

Utility of the SARC-F Questionnaire for Sarcopenia Screening in Patients with Chronic Liver Disease: A Multicenter Cross-Sectional Study in Japan

Diagnosing sarcopenia is challenging. This multicenter cross-sectional study aimed to evaluate the utility of the SARC-F score system for identifying sarcopenia in patients with chronic liver disease (CLD). We enrolled 717 patients from five participating centers who completed the SARC-F between Nov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanai, Tatsunori, Hiraoka, Atsushi, Shiraki, Makoto, Sugimoto, Ryosuke, Taniki, Nobuhito, Hiramatsu, Akira, Nakamoto, Nobuhiro, Iwasa, Motoh, Chayama, Kazuaki, Shimizu, Masahito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348368/ https://www.ncbi.nlm.nih.gov/pubmed/34362231 http://dx.doi.org/10.3390/jcm10153448

Ejemplares similares

Validation of the Italian Version of the SARC-F Questionnaire to Assess Sarcopenia in Older Adults
por: Perna, Simone, et al.
Publicado: (2022)

Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume
por: Imai, Kenji, et al.
Publicado: (2017)

Reliability and Validity of SARC-F Questionnaire to Assess Sarcopenia Among Vietnamese Geriatric Patients
por: Nguyen, Tam Ngoc, et al.
Publicado: (2020)

Accuracy and prognostic ability of the SARC-F questionnaire and Ishii's score in the screening of sarcopenia in geriatric inpatients
por: Li, Min, et al.
Publicado: (2019)

Sarcopenia screening in elderly with Alzheimer’s disease: performances of the SARC-F-3 and MSRA-5 questionnaires
por: Bramato, Giulia, et al.
Publicado: (2022)

Comparing SARC-CalF With SARC-F for Screening Sarcopenia in Adults With Type 2 Diabetes Mellitus
por: Xu, Zeru, et al.
Publicado: (2022)

Diagnostic performance of calf circumference, SARC-F, and SARC-CalF for possible sarcopenia screening in Indonesia
por: Kandinata, Stefanus G., et al.
Publicado: (2023)

Diagnostic performance of SARC-F and SARC-CalF in screening for sarcopenia in older adults in Northern Brazil
por: Barreto de Lima, Alex, et al.
Publicado: (2023)

Sarcopenia for predicting mortality among elderly nursing home residents: SARC-F versus SARC-CalF
por: Yang, Ming, et al.
Publicado: (2019)

Accuracy of Calf Circumference Measurement, SARC-F Questionnaire, and Ishii's Score for Screening Stroke-Related Sarcopenia
por: Yao, Ruihong, et al.
Publicado: (2022)

Polish Translation and Validation of the SARC-F Tool for the Assessment of Sarcopenia
por: Zasadzka, Ewa, et al.
Publicado: (2020)

Identifying Patients with Osteoarthritis at Risk of Sarcopenia using the SARC-F
por: Lovett, Maggie, et al.
Publicado: (2021)

Validation of a proxy‐reported SARC‐F questionnaire for current and retrospective screening of sarcopenia‐related functional impairments
por: Maurus, Johannes, et al.
Publicado: (2021)

Validity of the SARC-F questionnaire in assessing sarcopenia in patients with chronic kidney disease: a cross-sectional study
por: Du, Wen, et al.
Publicado: (2023)

Identification of Probable sarcopenia based on SARC-F and SARC-CalF in older adults from a low-resource setting
por: Vidal-Cuellar, Claudia L., et al.
Publicado: (2022)

SARC-F Capacity to Tracking Sarcopenia in Women From Manaus-Am
por: Faber, Myrian, et al.
Publicado: (2020)

Prognostic utility of self‐reported sarcopenia (SARC‐F) in the Multiethnic Cohort
por: Wu, Anna H., et al.
Publicado: (2022)

Prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis
por: Hanai, Tatsunori, et al.
Publicado: (2023)

Evaluation of SARC-F and SARC-CalF for sarcopenia screening in patients with chronic musculoskeletal pain: A prospective cross-sectional study
por: Tsuji, Hironori, et al.
Publicado: (2022)

Homeostatic Model Assessment of Insulin Resistance for Predicting the Recurrence of Hepatocellular Carcinoma after Curative Treatment
por: Imai, Kenji, et al.
Publicado: (2019)

Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis
por: Hanai, Tatsunori, et al.
Publicado: (2020)

Sustained virological response by direct-acting antivirals reduces the recurrence risk of hepatitis C-related hepatocellular carcinoma after curative treatment
por: Imai, Kenji, et al.
Publicado: (2020)

Late Evening Snack with Branched-Chain Amino Acids Supplementation Improves Survival in Patients with Cirrhosis
por: Hanai, Tatsunori, et al.
Publicado: (2020)

Prevalence of sarcopenia in pre-frail community dwelling older adult and utility of SARC-F, SARC-CalF and calf circumference in case finding
por: Lim, Jia Yi, et al.
Publicado: (2020)

Validation of SARC-F-Proxy for the Screening of Sarcopenia in Older Patients with Cognitive Impairment
por: Lamers, Scott, et al.
Publicado: (2023)

Association of SARC-F Questionnaire and Mortality in Prevalent Hemodialysis Patients
por: Lin, Yu-Li, et al.
Publicado: (2020)

SARC-F for sarcopenia screening in community-dwelling older adults: Are 3 items enough?
por: Yang, Ming, et al.
Publicado: (2018)

Polish version of SARC-F to assess sarcopenia in older adults: An examination of reliability and validity
por: Krzymińska-Siemaszko, Roma, et al.
Publicado: (2020)

Developing a UK sarcopenia registry: recruitment and baseline characteristics of the SarcNet pilot
por: Witham, Miles D, et al.
Publicado: (2021)

SARC‐F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes
por: Malmstrom, Theodore K., et al.
Publicado: (2015)

Novel Adaption of the SARC-F Score to Classify Pediatric Hemato-Oncology Patients with Functional Sarcopenia
por: Verwaaijen, Emma J., et al.
Publicado: (2023)

Increased visceral fat volume raises the risk for recurrence of hepatocellular carcinoma after curative treatment
por: Imai, Kenji, et al.
Publicado: (2018)

Rapid Depletions of Subcutaneous Fat Mass and Skeletal Muscle Mass Predict Worse Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib
por: Imai, Kenji, et al.
Publicado: (2019)

Rapid Depletion of Subcutaneous Adipose Tissue during Sorafenib Treatment Predicts Poor Survival in Patients with Hepatocellular Carcinoma
por: Imai, Kenji, et al.
Publicado: (2020)

Increased Visceral Adipose Tissue and Hyperinsulinemia Raise the Risk for Recurrence of Non-B Non-C Hepatocellular Carcinoma after Curative Treatment
por: Imai, Kenji, et al.
Publicado: (2021)

The usefulness of SARC-F
por: Piotrowicz, Karolina, et al.
Publicado: (2021)

Cross-cultural adaptation and validation of the Greek Version of the SARC-F for evaluating sarcopenia in Greek older adults
por: Tsekoura, Maria, et al.
Publicado: (2020)

Screening Tools for Sarcopenia in Mild to Moderate Parkinson’s Disease: Assessing the Accuracy of SARC-F and Calf Circumference
por: de Luna, João Rafael Gomes, et al.
Publicado: (2023)

Sarcopenia Risk Evaluation in a Sample of Hospitalized Elderly Men and Women: Combined Use of the Mini Sarcopenia Risk Assessment (MSRA) and the SARC-F
por: Rossi, Andrea P., et al.
Publicado: (2021)

Skeletal Muscle Depletion Predicts the Prognosis of Patients with Hepatocellular Carcinoma Treated with Sorafenib
por: Imai, Kenji, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4evq6gf358sa8hhccca6c670s5